Edition:
United States

Wanbury Ltd (WANB.NS)

WANB.NS on National Stock Exchange of India

60.65INR
27 Feb 2017
Change (% chg)

-- (--)
Prev Close
Rs60.65
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
25,000
52-wk High
Rs75.40
52-wk Low
Rs36.40

WANB.NS

Chart for WANB.NS

About

Wanbury Limited is a pharmaceutical company. The Company offers active pharmaceutical ingredient (API) in over 70 countries. The Company offers products in the categories, such as anti-diabetic, anti-depressant, anti-histaminic, anti-inflammatory, anti-depressant, anti-arthritis, anti-thrombotic, anti-epileptic and anti-hyperten... (more)
No analyst recommendations are available for WANB.NS.

Overall

Beta: 1.47
Market Cap(Mil.): Rs1,253.66
Shares Outstanding(Mil.): 20.27
Dividend: --
Yield (%): --

Financials

  WANB.NS Industry Sector
P/E (TTM): -- 28.84 29.63
EPS (TTM): -- -- --
ROI: -- 13.44 12.96
ROE: -- 14.34 14.11

BRIEF-Wanbury Ltd Dec-qtr loss narrows

* Dec quarter net loss 6.5 million rupees versus loss 69.9 million rupees year ago

Feb 14 2017

BRIEF-Wanbury Ltd posts Sept-qtr profit

* Sept quarter net profit 70.7 million rupees versus loss 24.4 million rupees year ago

Nov 29 2016

BRIEF-India's Wanbury expects no material impact from Thane FDA notice

* India's Wanbury says show cause notice from Thane FDA does not have material impact on operations Further company coverage:

Nov 08 2016

More From Around the Web

Earnings vs. Estimates

No consensus analysis data available.